NewsApp (Free)  Read news as it happens Download NewsApp
Available on    Rediff News  All News  » Business » 'Novartis
case: Supreme Court ruling wise and balanced'  'Novartis case:
Supreme Court ruling wise and balanced'  Last updated on: April
10, 2013 14:31 IST  Sudip ChaudhuriThe Supreme Court recently
rejected the plea of Novartis AG for patent protection of its
anti-cancer drug Glivec.  The Supreme Court  judgement (pages 22
-26) quite extensively quoted from Sudip Chaudhuri’s book The
WTO and India’s Pharmaceuticals Industry (Patent Protection,
TRIPS, and Developing Countries), which highlighted the adverse
effects of product patents and positive effects of its abolition
in the pharma industry in India.  Professor of Economics at the
Indian Institute of Management Calcutta, Chaudhuri has done
extensive research on products patents, pharmaceutical industry,
industrial policy and the like.  In an interview to rediff.coms
Indrani Roy, he talked about why Novartis ruling is a landmark,
what effect will it